Up next
Share article
The post has been shared by 0 people.
Mail 0
LinkedIn 0
Twitter 0

Podcast 29: FDA Addresses Supply Constraints Due to COVID-19; Plus, Packaging Suppliers Expand

In this podcast we take a look at the FDA’s new guidance to facilitate changes to container-closure-system components due to supply constraints, plus updates from suppliers of materials used to deliver COVID-19 vaccines, treatments and other parenteral drugs. For the text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)

2020 in Review: The Top 10 Developments

  • FDA addresses supply constraints
  • Suppliers increase production

Sponsor: Vetter Pharma International GmbH

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Podcast 44: What’s Trending: Parenteral Drug Development & Manufacturing

What are some key trends and issues arising in parenteral drug development and manufacturing? From more complex molecules and modalities and sterile drug-product capacity market shifts, DCAT Value Chain Insights…

Podcast 43: CDMOs/CMOs: The Movers and Shakers of 2023

As 2023 comes to a close, what were the largest mergers and acquisitions and expansions made by CDMOs/CMOs in 2023? DCAT Value Chain Insights looks at which companies topped the…

Podcast 42: CDMO/CMO Mid-Year Review: Tracking the Key Moves Thus Far in 2023 

As we near the mid-year mark, what have been the key moves—mergers and acquisitions, expansions, and new CDMOs entering the market—thus far in 2023? DCAT Value Chain Insights takes an…

Podcast 41: API Alert: EU Proposes New Requirements To Secure Pharma Supply Chains 

The European Commission has issued its long-awaited proposal to reform pharmaceutical legislation in the EU, the first major overhaul in 20 years, which includes new requirements to address drug shortages…